Home・Lista de Ações・Abbott Laboratories

Abbott Laboratories

Fechado

SetorSaúde

108.26 -0.44

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

108.2

Máximo

109.05

Indicadores-chave
By Trading Economics
Rendimento	-149M 928M
Vendas	1.4B 13B
P/E Médio do Setor	35.715 56.659
EPS	1.31
Rendimento de Dividendos	2.21
Margem de lucro	7.369
Funcionários	122,000
EBITDA	-465M 1.8B

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+14.77% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	2.21% 2.18%
Próximos Ganhos	14 de out. de 2026
Próxima data de ex-dividendo	14 de out. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	27B 191B
Abertura anterior	108.7
Fecho anterior	108.26

Abbott Laboratories Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

4 de set. de 2026, 20:07 UTC

Abbott Laboratories shares are lower, influenced by a strong jobs report that increased selling pressure across risk assets. The stock remains near its one-month trading range low.

3 de set. de 2026, 23:31 UTC

Abbott Laboratories shares declined in after-market trading, reflecting ongoing weakness. The stock is near the lower end of its one-month range.

2 de set. de 2026, 23:56 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting a decline since Wednesday's close amid weaker-than-expected job growth reported by ADP.

1 de set. de 2026, 23:51 UTC

Abbott Laboratories shares are higher in after-market hours amid notable trading activity. Rising oil prices and inflation concerns may influence Federal Reserve policy decisions.

31 de ago. de 2026, 23:32 UTC

Correlated Moves

Abbott Laboratories sees gains in after-market trading, reflecting strength in the health care equipment sector and broader positive trends among correlated assets.

28 de ago. de 2026, 23:16 UTC

Correlated Moves

Abbott Laboratories shares are higher in after-market hours, following a modest gain earlier, alongside Medtronic PLC's advance in the health care equipment sector.

27 de ago. de 2026, 22:51 UTC

Abbott Laboratories shares are trading higher in after-market hours, reversing three consecutive daily declines. No specific news was identified to explain the movement.

26 de ago. de 2026, 23:21 UTC

Abbott Laboratories is higher in after-market hours, reflecting broader market gains. The stock remains above its 20-day moving average despite recent fluctuations.

25 de ago. de 2026, 23:26 UTC

Abbott Laboratories shares declined after-market, with no specific news identified. Broader market sentiment was affected by falling crude oil prices amid eased geopolitical tensions.

24 de ago. de 2026, 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market weakness and geopolitical tensions are contributing to the price movement.

21 de ago. de 2026, 23:01 UTC

Abbott Laboratories shares were lower in after-market trading, despite being above the 20-day moving average and near the upper end of their one-month range.

20 de ago. de 2026, 23:01 UTC

News

Abbott Laboratories settles litigation for $670 million over preterm infant formulas, trading lower in after-market hours following the news.

19 de ago. de 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours following a volatile session, despite trading above their 20-day moving average. No specific news was identified.

18 de ago. de 2026, 23:16 UTC

Shares of Abbott Laboratories are higher in after-market trading, remaining above the 20-day moving average and near the upper end of the one-month range.

17 de ago. de 2026, 23:41 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market volatility is linked to rising crude oil prices and geopolitical tensions.

14 de ago. de 2026, 23:02 UTC

Abbott Laboratories shares are trading higher in after-market hours, showing strength above the 20-day moving average despite mixed market sentiment and declining U.S. retail sales.

13 de ago. de 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

12 de ago. de 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified for the decline. Broader market optimism follows recent inflation data.

11 de ago. de 2026, 19:16 UTC

News

Abbott Laboratories announced a partnership with Google Health to enhance glucose management through AI. Shares are trading higher amid positive market sentiment.

10 de ago. de 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

7 de ago. de 2026, 23:06 UTC

Abbott Laboratories shares declined slightly in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

6 de ago. de 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, amid broader market weakness and rising initial jobless claims contributing to tightening expectations.

5 de ago. de 2026, 23:02 UTC

Abbott Laboratories shares are lower in after-market trading, following a brief peak post-close. Broader market conditions may be influencing sentiment amid weaker U.S. job growth data.

4 de ago. de 2026, 20:06 UTC

Abbott Laboratories shares are lower today, tracking broader market declines amid falling crude oil prices and ongoing discussions about potential peace talks.

3 de ago. de 2026, 23:06 UTC

Abbott Laboratories shares are near unchanged in after-market trading, positioned 7.52% above the 20-day moving average and near the upper end of the one-month range.

31 de jul. de 2026, 23:01 UTC

Abbott Laboratories shares are modestly higher in after-market trading. The stock remains elevated, 7.16% above its 20-day moving average.

30 de jul. de 2026, 23:51 UTC

Abbott Laboratories shares are higher in after-market trading, recovering from earlier losses. The stock trades significantly above its 20-day moving average.

29 de jul. de 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, continuing recent volatility amid mixed global market performance and rising geopolitical tensions in the Middle East.

28 de jul. de 2026, 23:02 UTC

Abbott Laboratories shares are higher in after-market hours, showing notable volatility post-close while remaining above the 20-day moving average. No specific news was identified.

27 de jul. de 2026, 23:02 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified to explain the movement. Broader market sentiment may be influencing the decline.

Comparação entre Pares

Variação de preço

Abbott Laboratories Previsão

Preço-alvo

By TipRanks

14.77% parte superior

Previsão para 12 meses

Média 124.33 USD 14.77%

Máximo 135 USD

Mínimo 112 USD

Com base em 15 analistas de Wall Street que oferecem metas de preço de 12 meses para Abbott Laboratories - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

15 ratings

Comprar

Manter

Vender

Com base em 15 analistas que deram avaliações de ações para Abbott Laboratories - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.